Aug 19(Reuters) – The U.S. Food and Drug Administration approved Ultragenyx Pharmaceutical's gene therapy to treat a rare metabolic disorder, the company said on Wednesday. (Reporting by Padmanabhan
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Coty sees weak quarterly profit, withholds annual forecasts in 'transition year'
By Neil J Kanatt Aug 19 (Reuters) - Coty on Wednesday forecast current-quarter earnings below…
Britain's Queen Camilla attends first day of York's Ebor festival
VIDEO SHOWS: BRITAIN'S QUEEN CAMILLA SPEAKING TO ATTENDEES, PRESENTING TROPHIES AT YORK'S EBOR FESTIVAL TEMPLATE…
Tennis-Paul ousts top seed Zverev in to reach Cincinnati quater-finals
Aug 19 (Reuters) - Tommy Paul saved a match point to defeat top seed Alexander…
